Muxing Kang

1.5k total citations
33 papers, 1.1k citations indexed

About

Muxing Kang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Muxing Kang has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Surgery and 12 papers in Oncology. Recurrent topics in Muxing Kang's work include Pancreatic and Hepatic Oncology Research (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Pancreatic function and diabetes (5 papers). Muxing Kang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Pancreatic function and diabetes (5 papers). Muxing Kang collaborates with scholars based in China, United States and India. Muxing Kang's co-authors include Yulian Wu, Qingqu Guo, Qiuping Xie, Yulian Wu, Bingbo Zhang, Haijie Han, Qiao Jin, Peisen Zhang, Yi Hou and Xiaohong Chen and has published in prestigious journals such as Journal of the American Chemical Society, Gastroenterology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Muxing Kang

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muxing Kang China 19 579 328 272 189 154 33 1.1k
Qiyun Tang China 23 625 1.1× 282 0.9× 366 1.3× 179 0.9× 143 0.9× 65 1.3k
Thanh H. Dellinger United States 22 542 0.9× 424 1.3× 233 0.9× 203 1.1× 96 0.6× 77 1.3k
Peng Gong China 21 467 0.8× 399 1.2× 216 0.8× 145 0.8× 158 1.0× 68 1.2k
Yao Yuan China 20 855 1.5× 500 1.5× 376 1.4× 154 0.8× 170 1.1× 72 1.6k
Quan-Xing Ni China 18 462 0.8× 638 1.9× 282 1.0× 211 1.1× 223 1.4× 25 1.3k
Huanrong Lan China 22 474 0.8× 448 1.4× 254 0.9× 106 0.6× 174 1.1× 62 1.1k
Joshua J. Souchek United States 16 462 0.8× 326 1.0× 245 0.9× 101 0.5× 163 1.1× 22 1.0k
Yang Fu China 21 506 0.9× 289 0.9× 141 0.5× 216 1.1× 136 0.9× 61 1.1k
Haiping Jiang China 18 562 1.0× 385 1.2× 226 0.8× 92 0.5× 176 1.1× 45 1.2k
Ryszard Smolarczyk Poland 18 647 1.1× 373 1.1× 214 0.8× 120 0.6× 198 1.3× 48 1.4k

Countries citing papers authored by Muxing Kang

Since Specialization
Citations

This map shows the geographic impact of Muxing Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muxing Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muxing Kang more than expected).

Fields of papers citing papers by Muxing Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muxing Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muxing Kang. The network helps show where Muxing Kang may publish in the future.

Co-authorship network of co-authors of Muxing Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Muxing Kang. A scholar is included among the top collaborators of Muxing Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muxing Kang. Muxing Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Shenbin, et al.. (2024). Prognostic effect of CEA, AFP, CA19‑9 and CA242 for recurrence/metastasis of gastric cancer following radical gastrectomy. Molecular and Clinical Oncology. 22(2). 17–17. 2 indexed citations
2.
Chen, Jing, Kuai Liu, Yikai Luo, et al.. (2023). Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma. Gastroenterology. 165(1). 88–103. 45 indexed citations
3.
Wang, Jun, Beidi Wang, Biting Zhou, et al.. (2022). A novel immune-related lncRNA pair signature for prognostic prediction and immune response evaluation in gastric cancer: a bioinformatics and biological validation study. Cancer Cell International. 22(1). 69–69. 7 indexed citations
5.
Kang, Muxing, Xiaojing Ma, Guofeng Chen, et al.. (2022). Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach. Translational Oncology. 19. 101380–101380. 9 indexed citations
7.
Zhu, Hongyu, Yulian Wu, Muxing Kang, & Bo Zhang. (2020). MiR-877 suppresses gastric cancer progression by downregulating AQP3. Journal of International Medical Research. 48(6). 1220703213–1220703213. 18 indexed citations
8.
Wang, Jun, Shaojun Yu, Guofeng Chen, et al.. (2020). A novel prognostic signature of immune‐related genes for patients with colorectal cancer. Journal of Cellular and Molecular Medicine. 24(15). 8491–8504. 44 indexed citations
9.
Zhang, Yue‐Feng, Yizhao Zhou, Bo Zhang, et al.. (2019). Pancreatic cancer-derived exosomes promoted pancreatic stellate cells recruitment by pancreatic cancer. Journal of Cancer. 10(18). 4397–4407. 55 indexed citations
10.
Huang, Yi, Guofeng Chen, Lele Lin, et al.. (2019). Resection of GIST in the duodenum and proximal jejunum: A retrospective analysis of outcomes. European Journal of Surgical Oncology. 45(10). 1950–1956. 18 indexed citations
11.
Zhang, Yuefeng, Shifei Huang, Pengping Li, et al.. (2018). Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1/3. Cancer Letters. 431. 190–200. 39 indexed citations
12.
Kang, Muxing, Wen Zheng, Qing Chen, et al.. (2018). Thymidylate synthase prompts metastatic progression through the dTMP associated EMT process in pancreatic ductal adenocarcinoma. Cancer Letters. 419. 40–52. 7 indexed citations
13.
Kang, Muxing, Xiaoli Jin, Guofeng Chen, et al.. (2018). Concurrent Treatment with Anti-DLL4 Enhances Antitumor and Proapoptotic Efficacy of a γ-Secretase Inhibitor in Gastric Cancer. Translational Oncology. 11(3). 599–608. 5 indexed citations
14.
Wang, Lantian, Bo Zhang, Wen Zheng, et al.. (2017). Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway. Scientific Reports. 7(1). 5384–5384. 82 indexed citations
15.
Zheng, Wen, et al.. (2016). Deguelin inhibits proliferation and migration of human pancreatic cancer cells in vitro targeting hedgehog pathway. Oncology Letters. 12(4). 2761–2765. 21 indexed citations
16.
Chen, Ying, Muxing Kang, Wenjie Lu, et al.. (2012). DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer. Journal of Cancer Research and Clinical Oncology. 138(9). 1463–1474. 49 indexed citations
17.
Kang, Muxing, Biao Jiang, Bin Xu, et al.. (2012). Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer. Cancer Letters. 330(1). 11–21. 34 indexed citations
18.
Chen, Ying, Qingqu Guo, Bingbo Zhang, et al.. (2012). Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Oncology Letters. 4(4). 792–798. 18 indexed citations
19.
20.
Guo, Qingqu, et al.. (2010). Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes. Journal of Cancer Research and Clinical Oncology. 136(11). 1627–1631. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026